| High-grade serous ovarian cancer: the clone wars A Salomon-Perzyński, M Salomon-Perzyńska, B Michalski, ... Archives of gynecology and obstetrics 295, 569-576, 2017 | 50 | 2017 |
| Immunochemotherapy for Richter syndrome: current insights B Puła, A Salomon-Perzyński, M Prochorec-Sobieszek, K Jamroziak ImmunoTargets and therapy, 1-14, 2019 | 24 | 2019 |
| Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma A Salomon-Perzyński, A Walter-Croneck, L Usnarska-Zubkiewicz, ... Advances in Medical Sciences 64 (2), 349-355, 2019 | 22 | 2019 |
| POEMS syndrome: real world experience in diagnosis and systemic therapy-108 patients multicenter analysis A Jurczyszyn, JJ Castillo, M Olszewska-Szopa, L Kumar, S Thibaud, ... Clinical Lymphoma Myeloma and Leukemia 22 (5), 297-304, 2022 | 17 | 2022 |
| CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma J Barankiewicz, A Salomon-Perzyński, I Misiewicz-Krzemińska, ... Cancers 14 (18), 4492, 2022 | 15 | 2022 |
| The management of hematologic malignancies during the COVID-19 pandemic I Hus, A Salomon-Perzyński, K Tomasiewicz, T Robak Expert Opinion on Pharmacotherapy 22 (5), 565-582, 2021 | 14 | 2021 |
| VEGF–targeted therapy for the treatment of cervical cancer–literature review M Salomon-Pierzyńska, B Rembielak-Stawecka, B Michalski, A Perzyński, ... Ginekologia polska 85 (6), 2014 | 14 | 2014 |
| Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications A Salomon-Perzyński, K Jamroziak, E Głodkowska-Mrówka Diagnostics 11 (9), 1534, 2021 | 10 | 2021 |
| The impact of cytogenetic evolution and acquisition of del (17p) on the prognosis of patients with multiple myeloma. A Salomon-Perzyński, A Bluszcz, A Krzywdzińska, Z Spyra-Gorny, ... Polish Archives of Internal Medicine 130 (6), 483-491, 2020 | 8 | 2020 |
| High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell … I Hus, J Mańko, D Jawniak, A Jurczyszyn, G Charliński, ... Oncology Letters 18 (6), 5811-5820, 2019 | 7 | 2019 |
| Cladribine combined with low-dose cytarabine as frontline treatment for unfit elderly acute myeloid leukemia patients: results from a prospective multicenter study of Polish … BK Budziszewska, A Salomon-Perzyński, K Pruszczyk, J Barankiewicz, ... Cancers 13 (16), 4189, 2021 | 6 | 2021 |
| The up-to-date role of biologics for the treatment of chronic lymphocytic leukemia I Hus, A Salomon-Perzyński, T Robak Expert Opinion on Biological Therapy 20 (7), 799-812, 2020 | 6 | 2020 |
| The role of daratumumab in the treatment of patients with relapsed/refractory plasma cell myeloma AS Perzyński, K Jamroziak Hematology in Clinical Practice 8 (4), 255-264, 2017 | 6 | 2017 |
| Doksycyklina w terapii amyloidozy układowej z zajęciem serca J Łyczkowska-Piotrowska, A Salomon-Perzyński, A Końska, K Jamroziak Hematologia 9 (3), 202-207, 2018 | 5 | 2018 |
| The CRBN, CUL4A and DDB1 expression predicts the response to immunomodulatory drugs and survival of multiple myeloma patients J Barankiewicz, A Szumera-Ciećkiewicz, A Salomon-Perzyński, ... Journal of Clinical Medicine 10 (12), 2683, 2021 | 4 | 2021 |
| Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk* MYC preclinical model O Sokolowska, A Rodziewicz-Lurzynska, Z Pilch, H Kedzierska, ... Clinical and experimental medicine 23 (5), 1563-1572, 2023 | 3 | 2023 |
| Tracking clonal evolution of multiple myeloma using targeted next-generation DNA sequencing A Salomon-Perzyński, J Barankiewicz, M Machnicki, ... Biomedicines 10 (7), 1674, 2022 | 3 | 2022 |
| A specific CD44lo CD25lo subpopulation of regulatory T cells inhibits anti-leukemic immune response and promotes the progression in a mouse model of chronic lymphocytic leukemia A Goral, M Firczuk, K Fidyt, M Sledz, F Simoncello, K Siudakowska, ... Frontiers in Immunology 13, 781364, 2022 | 3 | 2022 |
| Real-world results of daratumumab monotherapy in heavily pretreated relapsed/refractory multiple myeloma in Poland: a prospective observational study of the Polish Myeloma Group A Salomon-Perzynski, A Walter-Croneck, L Usnarska-Zubkiewicz, ... Haematologica 102, 517-517, 2017 | 3 | 2017 |
| Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors B Puła, M Długosz-Danecka, A Salomon-Perzyński, A Szymczyk, ... Advances in Medical Sciences 65 (2), 371-377, 2020 | 2 | 2020 |
